COMPOSITION COMPRISING A HYALURONIC ACID-BASED POLYIONIC COMPLEX AND A SUPERABSORBENT POLYMER

A stable polyionic complex composition with cationic and anionic polymers, non-polymeric acids, and superabsorbent polymers enhances sebum control and provides a matte finish on the skin by forming a stable film that absorbs sebum, addressing the instability and limited effectiveness of hyaluronic acid-based complexes.

FR3141342B1Active Publication Date: 2024-11-01LOREAL SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
FR2022011244
Authority / Receiving Office
FR · FR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-10-28
Publication Date
2024-11-01
Estimated Expiration
2042-10-28

AI Technical Summary

Technical Problem

Hyaluronic acid-based polyionic complexes are unstable over time and provide limited sebum control, leading to reduced effectiveness in cosmetic applications.

Method used

A composition comprising a polyionic complex with specific ratios of cationic and anionic polymers, non-polymeric acids with multiple pKa values, superabsorbent polymers, and water, along with optional oils, forms a stable film that enhances sebum control by absorbing and retaining sebum, providing matte optical effects on the skin.

Benefits of technology

The composition achieves long-lasting sebum control and matte finish on the skin while maintaining stability and reducing stickiness, with the ability to form a cosmetic film that can be applied without aggregation.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

COMPOSITION COMPRISING A HYALURONIC ACID-BASED POLYIONIC COMPLEX AND A SUPERABSORBENT POLYMER. The present invention relates to a composition comprising: (a) at least one cationic polymer; (b) at least one anionic polymer; (c) at least one non-polymeric acid having two or more pKa values ​​or one or more salts thereof; (d) at least one superabsorbent polymer; and (e) water, wherein (b) the anionic polymer is selected from hyaluronic acids and their derivatives, and (d) the superabsorbent polymer is in the form of particles with an average particle size of 5 μm to 500 μm, preferably 10 μm to 400 μm, and more preferably 15 μm to 300 μm. The composition according to the present invention is stable over a long period. The composition according to the present invention can offer excellent sebum control effects. Figure for the abstract: none
Need to check novelty before this filing date? Find Prior Art

Description

Title of the invention: COMPOSITION COMPRISING A POLYIONIC COMPLEX BASED ON HYALURONIC ACID AND A SUPERABSORBENT POLYMER Technical field

[0001] The present invention relates to a composition comprising a polyionic complex and a superabsorbent polymer, as well as to a cosmetic process using the composition. CONTEXT OF ART

[0002] Hyaluronic acid is a predominant glucosaminoglycan found in the skin. Thus, fibroblasts synthesize mainly collagens, matrix glycoproteins other than collagens (fibronectin, laminin), proteoglycans and elastin. Keratinocytes, on the other hand, synthesize mainly sulfated glycosaminoglycans and hyaluronic acid. Hyaluronic acid is also called hyaluronan (HA).

[0003] Hyaluronic acid is present in the free state in the epidermis and dermis and is responsible for the turgor of the skin. This polysaccharide can in fact retain a large volume of water, corresponding to 1000 times its weight. In this sense, hyaluronic acid plays an important role in increasing the amounts of bound water in tissues, as well as in the mechanical properties of the skin and in the formation of wrinkles.

[0004] Hyaluronic acid is widely used as a cosmetic ingredient due to its high moisturizing effects.

[0005] Document WO 2021 / 125069 discloses a polyionic complex which may be composed of at least one cationic polymer and at least one anionic polymer, the anionic polymer being selected from hyaluronic acid and its derivatives. DISCLOSURE OF THE INVENTION

[0006] It has been found that a composition comprising a polyionic complex based on hyaluronic acid may become unstable over time and that the composition may exert relatively limited effects on sebum control.

[0007] Thus, an objective of the present invention is to provide a stable composition comprising a polyionic complex based on hyaluronic acid with enhanced sebum control effects.

[0008] The above objective of the present invention can be achieved by a composition, comprising:

[0009] (a) at least one cationic polymer;

[0010] (b) at least one anionic polymer;

[0011] (c) at least one non-polymeric acid having two or more pKa values or salt(s) thereof;

[0012] (d) at least one superabsorbent polymer; and

[0013] (e) water,

[0014] in which

[0015] the (b) anionic polymer is chosen from hyaluronic acids and their derivatives, And

[0016] the (d) superabsorbent polymer is in the form of particles with an average particle size of 5 qm to 500 qm, preferably 10 qm to 400 qm, and more preferably 15 qm to 300 qm.

[0017] The (a) cationic polymer may have at least one positively chargeable and / or positively charged moiety selected from the group consisting of a primary, secondary or tertiary amino group, a quaternary ammonium group, a guanidine group, a biguanide group, an imidazole group, an imino group and a pyridyl group.

[0018] The (a) cationic polymer may be selected from the group consisting of alkyldiallylamine cyclopolymers and dialkyldiallylammonium cyclopolymers such as (co)polydiallyldialkyl ammonium chloride, (co)polyamines such as chitosans and (co)polylysines, cationic (co)polyamino acids such as collagen, cationic cellulose polymers and their salts.

[0019] The amount of the (a) cationic polymer(s) in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.1% to 5% by weight, relative to the total weight of the composition.

[0020] The composition according to the present invention may comprise at least two hyaluronic acids of different molecular weights, preferably a first hyaluronic acid of a molecular weight of 100 kDa or less and a second hyaluronic acid of a molecular weight of 500 kDa or more, and preferably a first hyaluronic acid of a molecular weight of 50 kDa or less and a second hyaluronic acid of a molecular weight of 1000 kDa or more, as the (b) anionic polymers.

[0021] The amount of the (b) anionic polymer(s) in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.1% to 5% by weight, relative to the total weight of the composition.

[0022] The (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof may be an organic acid or salts thereof, preferably a hydrophilic or water-soluble organic acid or one or more salts thereof and, more preferably, phytic acid or salts thereof.

[0023] The amount of (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.1% to 5% by weight, relative to the total weight of the composition.

[0024] The (d) superabsorbent polymer may be chosen from crosslinked (meth)acrylic or (meth)acrylate polymers, starches grafted with one or more acrylic or acrylate polymer(s) and mixtures thereof.

[0025] The amount of the (d) absorbent polymer in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.01% to 5% by weight, relative to the total weight of the composition.

[0026] The amount of (e) water in the composition according to the present invention may be from 50% to 95% by weight, preferably from 60% to 90% by weight and, more preferably, from 70% to 85% by weight, relative to the total weight of the composition.

[0027] The pH of the composition according to the present invention may be from 3 to 9, preferably from 3.3 to 8.0 and, more preferably, from 3.5 to 8.

[0028] The composition according to the present invention may further comprise (f) at least one oil.

[0029] The composition according to the present invention may be a cosmetic composition, preferably a cosmetic composition for the skin and more preferably a cosmetic skin care composition.

[0030] The present invention also relates to a cosmetic process for a keratinous substance such as skin, comprising:

[0031] the application to the keratinous material of the composition according to the present invention; and

[0032] drying the composition to form a cosmetic film on the keratinous substance. Best mode for carrying out the invention

[0033] After careful research, the inventors discovered that it was possible to provide a stable composition comprising a polyionic complex based on hyaluronic acid with enhanced sebum control effects.

[0034] Thus, the composition according to the present invention comprises:

[0035] (a) at least one cationic polymer;

[0036] (b) at least one anionic polymer;

[0037] (c) at least one non-polymeric acid having two or more pKa values or salt(s) thereof;

[0038] (d) at least one superabsorbent polymer; and

[0039] (e) water,

[0040] in which

[0041] the (b) anionic polymer is chosen from hyaluronic acids and their derivatives, And

[0042] the (d) superabsorbent polymer is in the form of particles with an average particle size of 5 qm to 500 qm, preferably 10 qm to 400 qm, and more preferably 15 qm to 300 qm.

[0043] The composition according to the present invention is stable for a long period of time. The composition is stable even if it includes oil or oils.

[0044] The composition according to the present invention can provide excellent sebum control effects. For example, the film formed by the composition according to the present invention can absorb sebum or oil and maintain it in the film even for a long time. The sebum control effects can lead to matte optical effects on a keratinous substance such as skin.

[0045] Furthermore, the composition according to the present invention can be applied without forming aggregations which may appear in the form of noodles.

[0046] Furthermore, the composition according to the present invention can provide cosmetic effects, such as moisturizing effects, based on hyaluronic acid or its derivatives.

[0047] Furthermore, the composition according to the present invention could be less sticky. For example, the stickiness of the composition according to the present invention comprising hyaluronic acid as an ingredient forming a polyionic complex could be reduced in comparison to a composition comprising hyaluronic acid without forming a polyionic complex.

[0048] The composition, process and other properties according to the present invention will be described in more detail hereinafter.

[0049] [Polyionic complex]

[0050] The composition according to the present invention includes (a) at least one cationic polymer, (b) at least one anionic polymer and (c) at least one non-polymeric acid having two or more pKa values ​​or salt(s) thereof, as explained below.

[0051] The ingredients (a), (b) and (c) mentioned above may form a polyionic complex. The polyionic complex may take the form of a particle. Two or more different types of particles may be present in combination. Thus, a single type of particle or a combination of different types of particles may be present in the composition according to the present invention.

[0052] If the polyionic complex is in particle form, the size of the particle can be between 5 nm and 100 pm, preferably from 100 nm to 50 pm, more preferably from 200 nm to 40 pm and even more preferably from 500 nm to 30 pm. A particle size of less than 1 pm can be measured by a dynamic light scattering method and a particle size of greater than 1 pm can be measured under an optical microscope. This particle size can be based on the number average diameter.

[0053] The amount of particle(s) in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more and, more preferably, 0.1% by weight or more, relative to the total weight of the composition.

[0054] Furthermore, the amount of particle(s) in the composition according to the present invention may be 15% by weight or less, preferably 10% by weight or less and, more preferably, 5% by weight or less, relative to the total weight of the composition.

[0055] The amount of particle(s) in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.1% to 5% by weight, relative to the total weight of the composition.

[0056] If the composition according to the present invention comprises (f) at least one oil, explained later, a plurality of particles may be present at the interface between (e) water and (f) oil. Thus, the particles may stabilize an emulsion. For example, if (e) water constitutes a continuous phase and (f) oil constitutes dispersed phases, the particles may form an O / W emulsion which may be similar to a so-called Pickering emulsion.

[0057] Alternatively, a plurality of particles may form a capsule having a hollow portion. The (f) oil may be present in the hollow portion. In other words, the (f) oil may be incorporated into the capsule. The wall of the capsule may be composed of a continuous layer or film formed from the particles. Without wishing to theorize, it is believed that the particles may be rearranged at the interface between (e) water and (f) oil to spontaneously form a capsule having a hollow portion to include (f) oil. For example, a continuous phase consisting of (e) water and dispersed phases consisting of (f) oil may form an O / W emulsion which may also be similar to a so-called Pickering emulsion.

[0058] This would mean that the particle itself is amphiphilic. The particle itself is insoluble in oil or water.

[0059] (Cationic polymer)

[0060] The composition according to the present invention may comprise (a) at least one cationic polymer. Two or more different types of cationic polymers may be used in combination. Thus, a single type of cationic polymer or a combination of different types of cationic polymers may be used.

[0061] The (a) cationic polymer has a positive charge density. The charge density of the (a) cationic polymer may be between 0.01 meq / g and 20 meq / g, preferably between 0.05 and 15 meq / g and, more preferably, between 0.1 and 10 meq / g.

[0062] It may be preferable that the molecular weight of the (a) cationic polymer is equal to or greater than 500, preferably equal to or greater than 1,000, more preferably equal to or greater than 2,000, and even more preferably equal to or greater than 3,000. Unless otherwise indicated in the descriptions, the term "molecular weight" means an average molecular weight number.

[0063] The (a) cationic polymer may have at least one positively chargeable and / or positively charged moiety selected from the group consisting of a primary, secondary or tertiary amino group, a quaternary ammonium group, a guanidine group, a biguanide group, an imidazole group, an imino group and a pyridyl group. The term "amino group" (primary) herein means a -NH2 group.

[0064] The (a) cationic polymer may be a homopolymer or a copolymer. By "copolymer" is meant both copolymers obtained from two kinds of monomers and those obtained from more than two kinds of monomers, such as terpolymers obtained from three kinds of monomers.

[0065] The (a) cationic polymer may be chosen from natural and synthetic cationic polymers. Non-limiting examples of (a) cationic polymers are given below.

[0066] (1) Homopolymers and copolymers derived from acrylic esters and amides or methacrylic and comprising at least one unit chosen from the units of the following formulas: O 0 W § IX AA TO i ! ---Rs Rf' ''R; | R;' ' Rv Rs R; -------Q------. 0^0 NH X' HAS R$--R'—R§ RS

[0067] in which:

[0068] R1 and R2, which may be identical or different, are chosen from hydrogen and alkyl groups comprising from 1 to 6 carbon atoms, for example methyl and ethyl groups;

[0069] R3, which may be the same or different, is chosen from hydrogen and CH3;

[0070] the symbols A, which may be identical or different, are chosen from linear or branched alkyl groups comprising from 1 to 6 carbon atoms, for example from 2 to 3 carbon atoms and hydroxyalkyl groups comprising from 1 to 4 carbon atoms;

[0071] R4, R5 and R6, which may be the same or different, are chosen from groups alkyl groups comprising from 1 to 18 carbon atoms and benzyl groups, and in at least one embodiment, alkyl groups comprising from 1 to 6 carbon atoms and

[0072] X is an anion derived from an inorganic or organic acid, such as methosulfate anions and halides, for example chloride and bromide.

[0073] The copolymers of family (1) above may also comprise at least one unit derived from comonomers which may be chosen from acrylamides, methacrylamides, diacetone acrylamides, acrylamides and methacrylamides substituted on the nitrogen atom with (C1-C4) lower alkyl groups, groups derivatives of acrylic or methacrylic acids and their esters, vinyl lactams such as vinylpyrrolidone and vinylcaprolactam and vinyl esters.

[0074] Here are some examples of copolymers of family (1):

[0075] copolymers of acrylamide and dimethylaminoethyl methacrylate quaternized with dimethyl sulfate or with a dimethyl halide,

[0076] copolymers of acrylamide and methacryloyloxyethyltrimethylammonium chloride described, for example, in European Patent Application No. 0 080 976,

[0077] copolymers of acrylamide and methacryloyloxyethyltrimethylammonium methosulfate,

[0078] copolymers of vinylpyrrolidone / dialkylaminoalkyl methacrylate or acrylate, quaternized or not, described, for example, in French Patents Nos. 2,077,143 and 2,393,573,

[0079] dimethylaminoethyl methacrylate / vinylca-prolactam / vinylpyrrolidone terpolymers,

[0080] vinylpyrrolidone / methacrylamidopropyldimethylamine copolymers, quaternized vinylpyrrolidone / dimethylaminopropylmethacrylamide copolymers and

[0081] crosslinked polymers of methacryloyloxy(Ci-C4)alkyltri(Ci-C4)alkylammonium salts such as polymers obtained by homopolymerization of dimethylaminoethyl methacrylate quaternized with methyl chloride, or by copolymerization of acrylamide with dimethylaminoethyl methacrylate quaternized with methyl chloride, the homo- or copolymerization being followed by crosslinking with a compound containing olefinic unsaturation, in particular methylenebisacrylamide.

[0082] (2) Cationic cellulose polymers such as cellulose ether derivatives comprising one or more quaternary ammonium groups described, for example, in French Patent No. 1,492,597, such as the polymers sold under the names “JR” (JR 400, JR 125, JR 30M) or “LR” (LR 400, LR 30M) by the company Union Carbide Corporation. These polymers are also defined in the CTFA dictionary as quaternary ammoniums of hydroxyethylcellulose reacted with an epoxide substituted by a trimethylammonium group.

[0083] It is preferable that the cationic cellulose polymers have at least one quaternary ammonium group, preferably a trialkyl quaternary ammonium group and, more preferably, a trimethyl quaternary ammonium group.

[0084] The quaternary ammonium group may be present in a quaternary ammonium group which may be represented by the following chemical formula (I):

[0085] in which

[0086] each of the groups R 1 and R 2 denotes a C 1 -C 3 alkyl group, preferably a methyl or ethyl group and, more preferably, a methyl group,

[0087] R3 denotes a Cr C24> alkyl group, preferably a methyl or ethyl group and, more preferably, a methyl group,

[0088] X- denotes an anion, preferably a halide and, more preferably, a chloride,

[0089] n denotes an integer between 0 and 30, preferably between 0 and 10 and, more preferably, equal to 0, and

[0090] R4 denotes a Cr C4> alkylene group, preferably an ethylene or propylene group.

[0091] The leftmost ether bond (-O-) in the above chemical formula (I) can attach to the sugar ring of the polysaccharide.

[0092] It is preferable that the group containing the quaternary ammonium is -O-CH2 -CH(OH)-CH2-N+(CH3)3.

[0093] (3) Cationic cellulose polymers such as cellulose copolymers and cellulose derivatives grafted with a water-soluble quaternary ammonium monomer and described, for example, in U.S. Patent No. 4,131,576, such as hydroxyalkylcelluloses, for example, hydroxymethyl-, hydroxyethyl- and hydroxypropylcelluloses grafted with, for example, a salt selected from methacryloyl-ethyltrimethylammonium, methacrylamidopropyltrimethylammonium and dimethyldiallylammonium salts.

[0094] Commercial products corresponding to these polymers include, for example, products sold under the names “Celquat® L 200” and “Celquat® H 100” by the company National Starch.

[0095] (4) Non-cellulosic cationic polysaccharides described in US patents Nos. 3,589,578 and 4,031,307, such as guar gums comprising cationic trialkylammonium groups, cationic hyaluronic acid and dextran hydroxypropyl trimonium chloride. Guar gums modified with a salt, for example the chloride, of 2,3-epoxypropyltrimethylammonium (guar hydroxypropyltrimonium chloride) may also be used.

[0096] These products are sold, for example, under the trade names JAGUAR® C13 S, JAGUAR® C15, JAGUAR® C17 and JAGUAR® C162 by the company MEYHALL.

[0097] (5) Polymers comprising piperazinyl units and alkylene groups or divalent hydroxyalkylene polymers comprising straight or branched chains, optionally interrupted with at least one entity chosen from oxygen, sulfur, nitrogen, aromatic and heterocyclic rings, as well as the oxidation and / or quaternization products of these polymers. These polymers are described, for example, in French patents Nos. 2,162,025 and 2,280,361.

[0098] (6) Water-soluble polyamino-amides prepared, for example, by polycon densification of an acidic compound with a polyamine; these polyamino-amides being optionally crosslinked with an entity chosen from epihalohydrins; diepoxides; dianhydrides; unsaturated dianhydrides; biunsaturated derivatives; bishalo-hydrins; bisazetidiniums; bishaloacydiamines; bisalkyl halides; oligomers resulting from the reaction of a difunctional compound which is reactive with an entity chosen from bishalohydrins; bisazetidiniums, bishaloacyl-diamines, bisalkyl halides; epihalohydrins; dihydroxides and bisunsaturated derivatives; the crosslinking agent being used in an amount ranging from 0.025 to 0.35 mole per amine group of polyaminoamides; these polyaminoamides being optionally alkylated or, if they comprise at least one tertiary amine function, they can be quaternized. These polymers are described, for example, in French patents Nos. 2,252,840 and 2,368,508.

[0099] (7) Polyamino-amide derivatives resulting from the condensation of polyamines of po- lyalkylene with polycarboxylic acids, followed by alkylation with di-functional agents, for example, adipic acid / dialkylaminohydroxyalkyldialkylenetriamine polymers in which the alkyl group comprises from 1 to 4 carbon atoms, such as methyl, ethyl and propyl groups, and the alkylene group comprises from 1 to 4 carbon atoms, such as an ethylene group. These polymers are described, for example, in French patent No. 1,583,363. In at least one embodiment, these derivatives may be selected from adipic acid / dimethylaminohydroxypropyldiethylenetriamine polymers.

[0100] (8) Polymers obtained by reaction of a polyalkylene polyamine comprising two primary amine groups and at least one secondary amine group, with a dicarboxylic acid selected from diglycolic acid and saturated aliphatic dicarboxylic acids comprising from 3 to 8 carbon atoms. The molar ratio of polyalkylene polyamine to dicarboxylic acid may vary from 0.8:1 to 1.4:1; the polyamino amide resulting from this reaction with epichlorohydrin in a molar ratio of epichlorohydrin to the secondary amine group of the polyamino amide ranging from 0.5:1 to 1.8:1. These polymers are described, for example, in U.S. Patent Nos. 3,227,615 and 2,961,347.

[0101] (9) Alkyldiallylamine cyclopolymers and dialkyldiallyl- cyclopolymers ammonium, such as homopolymers and copolymers comprising, as main constituent of the chain, at least one motif chosen from the motifs of formulas (Ia) and (Ib): --(OHg)t —ÇW —CHa— X. XH""" Rio

[0102] in which:

[0103] k and t, which may be identical or different, are equal to 0 or 1, the sum k+t being equal to 1;

[0104] R12 is chosen from hydrogen and methyl groups;

[0105] Rio and Rn, which may be the same or different, are selected from alkyl groups comprising from 1 to 6 carbon atoms, hydroxyalkyl groups in which the alkyl group comprises, for example, from 1 to 5 carbon atoms and lower amidoalkyl groups (Ci-C4), or R10 and Ru may form, with the nitrogen atom to which they are attached, heterocyclic groups such as piperidinyl and morpholinyl and

[0106] Y' is an anion such as bromide, chloride, acetate, borate, citrate, tartrate, bisulfate, bisulfite, sulfate and phosphate. These polymers are described, for example, in French patent No. 2,080,759 and in its certificate of addition 2,190,406.

[0107] In one embodiment, Rio and Ru, which may be the same or different, are selected from alkyl groups comprising from 1 to 4 carbon atoms.

[0108] Among these polymers, mention may be made, in particular, of (co)polydiallyldialkyl ammonium chloride such as the homopolymer of dimethyldiethylammonium chloride sold under the name “MERQUAT® 100” by the company CALGON (and its counterparts of low weight average molecular mass) and the copolymers of diallyl-dimethylammonium chloride and acrylamide sold under the name “MERQUAT® 550”.

[0109] Quaternary diammonium polymers comprising at least one repeating unit of formula (II): Ria Rw (II) • hf A r N* ■ | X | X Ru Ru

[0110] in which:

[0111] Rn, Ru, Ri5 and Ri6, which may be the same or different, are selected from aliphatic, alicyclic and aliphatic aryl groups comprising from 1 to 20 carbon atoms and lower aliphatic hydroxyalkyl groups, or Rn, R[4, Ri5 and Ri6, together or separately, with the nitrogen atoms to which they are attached, heterocycles alternatively comprising a second heteroatom other than nitrogen, or R13, R14, R15, and R16 which may be the same or different, are selected from linear or branched C1-C6 alkyl groups substituted by at least one group selected from alkyl groups, ester groups, acyl groups, amide groups, -CO-O-Rp-E groups and -CO-NH-R17-E groups, where R17 is a group alkylene and E is a quaternary ammonium group;

[0112] Ai and Bb which may be identical or different, are chosen from polymethylene groups comprising from 2 to 20 carbon atoms, which may be linear or branched, saturated or unsaturated, and which may comprise, linked or intercalated in the main chain, at least one entity chosen from aromatic rings, oxygen, sulfur, sulfoxide groups, sulfone groups, disulfide groups, amino groups, alkylamino groups, hydroxyl groups, quaternary ammonium groups, ureido groups, amide groups and ester groups, and

[0113] X denotes an anion derived from an inorganic or organic acid;

[0114] it being understood that Ab Ru and Ri5 can form, with the two nitrogen atoms to which they are attached, a piperazine cycle;

[0115] if Ai is chosen from linear or branched, saturated or unsaturated alkylene or hydroxyalkylene groups, Bi can be chosen from:

[0116] -(CH2)n-CO-E'-OC-(CH2)n-

[0117] where E' is chosen from:

[0118] a) glycolic residues of formula -OZO-, where Z is chosen from linear or branched hydrocarbon groups and groups of the following formulas:

[0119] -(CH2-CH2-O)X-CH2-CH2-

[0120] -[CH2-CH(CH3)-O]y-CH2-CH(CH3)-

[0121] where x and y, which may be the same or different, are chosen from integers ranging from 1 to 4, which represent a defined and unique degree of polymerization, and numbers ranging from 1 to 4, which represent an average degree of polymerization;

[0122] b) a bissecondary diamine residue such as piperazine derivatives;

[0123] c) bis-primary diamine residues of formula -NH-Y-NH-, in which Y is selected from linear or branched hydrocarbon groups and the divalent group -CH 2 -CH2 -SS -CH2 -CH 2 -CH2 -. and

[0124] d) ureylene groups of formula -NH-CO-NH-.

[0125] In at least one embodiment, X is an anion such as chloride or bromide.

[0126] Polymers of this type are described, for example, in French patents Nos. 2,320,330; 2,270,846; 2,316,271; 2,336,434; and 2,413,907 and in US patents Nos. 2,273,780; 2,375,853; 2,388,614; 2,454,547; 3,206,462; 2,261,002; 2,271,378; 3,874,870; 4,001,432; 3,929,990; 3,966,904; 4,005,193; 4,025,617; 4,025,627; 4,025,653; 4,026,945 and 4,027,020.

[0127] Among the non-limiting examples of these polymers are those comprising at least one repeating unit of formula (III): Rn Rw (III) ...... Ru Rh

[0128] in which Rn, RM, Ri5 and R[6, which may be the same or different, are chosen from alkyl and hydroxyalkyl groups comprising from 1 to 4 carbon atoms, n and p, which may be the same or different, are integers ranging from 2 to 20, and X is an anion derived from an inorganic or organic acid.

[0129] (11) polyquaternary ammonium polymers comprising units of formula (IV): (IV) ------—A--X" ) | Rts X"

[0130] in which:

[0131] R18, Rw, R2o and R2i, which may be the same or different, are chosen from hydrogen, methyl, ethyl, propyl, [3-hydroxyethyl, [3-hydroxypropyl, -CH 2CH2(OCH2CH2)POH, where p is chosen from integers between 0 and 6, provided that R[8, R[9, R20 and R2[ are not simultaneously hydrogen,

[0132] r and s, which may be identical or different, are chosen from integers ranging from 1 to 6,

[0133] q is chosen from integers ranging from 0 to 34,

[0134] - X denotes an anion, such as a halide and

[0135] A is chosen from dihalide radicals and -CH2-CH2-O-CH2-CH2-.

[0136] These compounds are described, for example, in European patent application No. 0 122 324.

[0137] (12) Quaternary polymers of vinylpyrrolidone and vinylimidazole.

[0138] Other examples of suitable cationic polymers include, but are not limited to, cationic proteins and cationic protein hydrolysates, polyalkyleneimines, such as polyethyleneimines, polymers comprising units selected from vinylpyridine and vinylpyridinium, condensates of polyamines and epichlorohydrin, quaternary polyureylenes and chitin derivatives.

[0139] According to one embodiment of the present invention, the (a) at least one cationic polymer is selected from cellulose ether derivatives comprising quaternary ammonium groups, such as the products sold under the name "JR 400" by the company UNION CARBIDE CORPORATION, cationic cyclopolymers, for example, homopolymers and copolymers of dimethyldiallylammonium chloride sold under the names MERQUAT® 100, MERQUAT® 550, and MERQUAT® S by the company CALGON, guar gums modified with a 2,3-epoxypropyltrimethylammonium salt and quaternary polymers of vinylpyrrolidone and vinylimidazole.

[0140] (13) Polyamines

[0141] As (a) cationic polymer, it is also possible to use (co)polyamines, which may be homopolymers or copolymers, with a plurality of amino groups. The amino group may be a primary, secondary, tertiary or quaternary amino group. The amino group may be present in the backbone of a polymer or in a pendant group, if present, of the (co)polyamines.

[0142] Examples of (co)polyamines include chitosan, (co)polylamines, (co)polyvinylamines, (co)polyanilines, (co)polyvinylimidazoles, (co)polydimethylaminoethylenemethacrylates, (co)polyvinylpyridines such as (co)poly-1-methyl-2-vinylpyridines, (co)polyimines such as (co)polyimines, (co)polypyridines such as (co)poly(quaternary pyridines), (co)polybiguanides such as (co)polyaminopropyl biguanides, (co)polylysines, (co)polyomithines, (co)polyarginines, (co)polyhistidines, aminodextrans, aminocelluloses, amino(co)polyvinylacetals and their salts.

[0143] As (co)polyamines, it is preferable to use (co)polylysines. Polylysine is well known. Polylysine can be a natural homopolymer of L-lysine which can be produced by bacterial fermentation. For example, polylysine can be e-Poly-L-lysine, commonly used as a natural preservative in food products. Polylysine is a polyelectrolyte that is soluble in polar solvents such as water, propylene glycol, and glycerol. Polylysine is commercially available in various forms, such as poly D-lysine and poly L-lysine. Polylysine can be in the form of a salt and / or a solution.

[0144] (14) Cationic polyamino acids

[0145] As (a) the cationic polymer, it may be possible to use cationic polyamino acids, which may be cationic homopolymers or copolymers, with a plurality of amino groups and carboxyl groups. The amino group may be a primary, secondary, tertiary, or quaternary amino group. The amino group may be present in the backbone of a polymer or in a pendant group, if present, of the cationic polyamino acids. The carboxyl group may be present in a pendant group, if present, of the cationic polyamino acids.

[0146] Examples of cationic polyamino acids include cationized collagen, cationized gelatin, hydroxypropyl stear-dimonium hydrolyzed wheat protein, hydroxypropyl cocodimonium hydrolyzed wheat protein, hydroxypropyltrimonium hydrolyzed conchiolin protein, hydroxypropyltrimonium steardimonium hydrolyzed soy protein, hydroxypropyltrimonium hydrolyzed soy protein, cocodimonium hydrolyzed soy protein, and the like.

[0147] The following descriptions relate to preferable embodiments of the (a) cationic polymer.

[0148] It may be preferable to choose the (a) cationic polymer to be chosen from cationic starches.

[0149] Examples of cationic starches include starches modified with a 2,3-epoxypropyltrimethylammonium salt (e.g. chloride), such as the product called starch hydroxypropyltrimonium chloride according to the INC1 nomenclature and sold under the name SENSOMER Cl-50 from Ondeo or Pencare™ DP 1015 from Ingredion.

[0150] It may also be preferable to choose the (a) cationic polymer to be chosen from cationic gums.

[0151] The gums may, for example, be selected from the group consisting of cassia gum, karaya gum, konjac gum, tragacanth gum, tara gum, acacia gum and gum arabic.

[0152] Examples of cationic gums include cationic polygalactomannan derivatives such as guar gum derivatives and cassia gum derivatives, e.g., CTFA: Guar Hydroxypropyltrimonium Chloride, Hydroxpropyl Guar Hydroxypropyltrimonium Chloride, and Cassia Hydroxypropyltrimonium Chloride. Guar hydroxypropyltrimonium chloride is commercially available under the Jaguar™ family of trade names from Rhodia Inc. and the N-Hance family of trade names from Ashland Inc. Cassia hydroxypropyltrimonium chloride is commercially available under the brand names Sensomer™ CT-250 and Sensomer™ CT-400 from Lubrizol Advanced Materials, Inc. or ClearHance™ from Ashland Inc.

[0153] It may be preferable that (a) the cationic polymer is selected from the group consisting of alkyldiallylamine cyclopolymers and dialkyldiallylammonium cyclopolymers such as (co)polydiallyldialkylammonium chloride, (co)polyamines such as (co)polylysines, cationic (co)polyamino acids such as cationized collagen, cationic cellulose polymers and their salts.

[0154] It may be more preferable that the (a) cationic polymer is selected from the group consisting of polylysines such as poly-a-lysine and poly-e-lysine, polyquaternium-4, polyquaternium-10, polyquaternium-24, polyquaternium-67, starch hydroxypropyltrimonium chloride, cassia hydroxypropyltrimonium chloride, chitosan and a mixture thereof.

[0155] The amount of the (a) cationic polymer(s) in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more and, more preferably, 0.1% by weight or more, relative to the total weight of the composition.

[0156] The amount of the (a) cationic polymer(s) in the composition according to the present invention may be 15% by weight or less, preferably 10% by weight or less and, more preferably, 5% by weight or less, relative to the total weight of the composition.

[0157] The amount of the (a) cationic polymer(s) in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.1% to 5% by weight, relative to the total weight of the composition.

[0158] (Anionic polymer)

[0159] The composition according to the present invention may include (b) at least one anionic polymer. Two or more different types of anionic polymers may be used in combination. Thus, a single type of anionic polymer or a combination of different types of anionic polymers may be used.

[0160] The (b) anionic polymer has a positive charge density. The charge density of the (b) anionic polymer may be from 0.1 meq / g to 20 meq / g, preferably from 1 to 15 meq / g and, more preferably, from 4 to 10 meq / g if the (b) anionic polymer is a synthetic anionic polymer, and the average degree of substitution of the (b) anionic polymer may be from 0.1 to 3.0, preferably from 0.2 to 2.7 and, more preferably, from 0.3 to 2.5 if the (b) anionic polymer is a natural anionic polymer.

[0161]

[0162]

[0163]

[0164] According to the present invention, the (b) anionic polymer is selected from hyaluronic acids and their derivatives. Hyaluronic acid can be represented by the following chemical formula. In the context of the present invention, the term "hyaluronic acid" covers in particular the basic unit of hyaluronic acid of formula:

[0165]

[0166]

[0167]

[0168]

[0169] It is the smallest fraction of hyaluronic acid comprising a dimer of disaccharide, namely D-glucuronic acid and N-acetylglucosamine. The term "hyaluronic acid and its derivatives" also includes, in the context of the present invention, a linear polymer comprising the polymeric unit described above, linked together in the chain via alternating [3(1,4) and [3(1,3)] glycosidic bonds, having a molecular weight (MW) which can vary between 380 and 13,000,000 daltons. This molecular weight depends largely on the source from which the hyaluronic acid is obtained and / or the preparation processes. The term "hyaluronic acid and its derivatives" also includes, in the context of the present invention, salts of hyaluronic acid. As salts, mention may be made of alkali metal salts such as sodium and potassium salts, alkaline earth metal salts such as magnesium salts, ammonium salts and mixtures thereof. In its natural state, hyaluronic acid is present in pericellular gels, in the basic substance of connective tissues of vertebrate organs such as the dermis and epithelial tissues and, in particular, in the epidermis, in the synovial fluid of joints, in the vitreous humor, in the human umbilical cord and in the crista galli process. Thus, the term “hyaluronic acid and its derivatives” includes all fractions or hyaluronic acid subunits having a molecular weight particularly in the molecular weight range mentioned above.

[0170] In the context of the present invention, hyaluronic acid fractions which do not have inflammatory activity are preferably used.

[0171] As an illustration of the different hyaluronic acid fractions, reference may be made to the document “Hyaluronan fragments: an information-rich System”, R. Stem et al., European Journal of Cell Biology 58 (2006) 699-715, which reviews the listed biological activities of hyaluronic acid as a function of its molecular weight.

[0172] According to a preferred embodiment of the present invention, the hyaluronic acid fractions suitable for the use covered by the present invention have a molecular weight of between 2,000 and 5,000,000 Da.

[0173] The hyaluronic acid fractions which may be suitable for the use covered by the present invention may have a molecular weight between 400,000 and 5,000,000 Da. In this case, the term used is high molecular weight hyaluronic acid.

[0174] Alternatively, hyaluronic acid fractions which may also be suitable for the use covered by the present invention have a molecular weight of between 200,000 and 400,000 Da. In this case, the term used is intermediate molecular weight hyaluronic acid.

[0175] As a further alternative, the hyaluronic acid fractions which may be suitable for the use covered by the present invention may have a molecular weight of less than 200,000 Da. In this case, the term used is low molecular weight hyaluronic acid.

[0176] Finally, the term "hyaluronic acid and its derivatives" also includes hyaluronic acid esters, in particular, those in which all or part of the carboxylic groups of the acid functions are esterified with oxyethylenated alkyls or alcohols, containing from 1 to 20 carbon atoms, in particular with a degree of substitution at the level of the D-glucuronic acid of the hyaluronic acid of between 0.5 and 50%.

[0177] Mention may in particular be made of methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. These esters have in particular been described in D. Campoccia et al. “Semisynthetic resorbable materials from hyaluronan esterification”, Biomaterials 19 (1998) 2101-2127.

[0178] The hyaluronic acid derivative may be, for example, acetylated hyaluronic acid or a salt thereof.

[0179] The molecular weights indicated above are also valid for hyaluronic acid esters.

[0180] The hyaluronic acid may in particular be hyaluronic acid supplied by the company Hyactive under the trade name CPN (MW: 10 to 150 kDa), by the company Soliance under the trade name Cristalhyal (MW: 10 ...

[0181] It is preferable that the composition according to the present invention comprises at least two hyaluronic acids of different molecular weights, as the (b) anionic polymers.

[0182] It may be preferable that the two hyaluronic acids are a combination of high molecular weight hyaluronic acid and medium molecular weight hyaluronic acid, a combination of high molecular weight hyaluronic acid and low molecular weight hyaluronic acid, or a combination of intermediate molecular weight hyaluronic acid and low molecular weight hyaluronic acid.

[0183] It may be preferable that the composition according to the present invention comprises a first hyaluronic acid of a molecular weight of 100 kDa or less and a second hyaluronic acid of a molecular weight of 500 kDa or more, and more preferably a first hyaluronic acid of a molecular weight of 50 kDa or less and a second hyaluronic acid of a molecular weight of 1000 kDa or more.

[0184] The weight ratio of the amount of the first hyaluronic acid: the amount of the second hyaluronic acid may be from 90:10 to 10:90, preferably from 80:20 to 20:80, more preferably from 70:30 to 30:70, and even more preferably from 60:40 to 40:60.

[0185] By using a combination of the at least two hyaluronic acids, of different molecular weights, the texture of the composition according to the present invention can be improved and the risk of noodle formation can be further reduced.

[0186] The amount of the (b) anionic polymer(s) in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more and, more preferably, 0.1% by weight or more, relative to the total weight of the composition.

[0187] Furthermore, the amount of the (b) anionic polymer(s) in the composition according to the present invention may be 15% by weight or less, preferably 10% by weight or less and, more preferably, 5% by weight or less, relative to the total weight of the composition.

[0188] The amount of the (b) anionic polymer(s) in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.1% to 5% by weight, relative to the total weight of the composition.

[0189] (Non-polymeric acid having two or more acid dissociation constants)

[0190] The composition according to the present invention comprises (c) at least one non-polymeric acid having two or more pKa values ​​or salt(s) thereof, i.e. at least one non-polymeric acid having two or more acid dissociation constants or salt(s) thereof. The pKa value (acid dissociation constant) is well known to those skilled in the art and should be determined at a constant temperature such as 25°C.

[0191] The (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof may be included in the polyionic complex which may be in the form of a particle. The non-polymeric acid having two or more pKa values ​​may act as a crosslinker for the (a) cationic polymer, or the (a) cationic polymer and the (b) anionic polymer.

[0192] The term "non-polymeric" herein means that the acid is not obtained by polymerization of two or more monomers. Therefore, non-polymeric acid does not correspond to an acid obtained by polymerizing two or more monomers such as polycarboxylic acid.

[0193] It is preferable that the molecular mass of the (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof is less than or equal to 1000, preferably less than or equal to 800 and, more preferably, less than or equal to 700.

[0194] There is no limit to the type of the (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof. Two or more different types of non-polymeric acids having two or more pKa values ​​or salts thereof may be used in combination. Thus, a single type of non-polymeric acid having two or more pKa values ​​or salt thereof or a combination of different types of non-polymeric acids having two or more pKa values ​​or salts thereof may be used.

[0195] Herein, the term "salt" means a salt formed by the addition of suitable base(s) to the non-polymeric acid having two or more pKa values, which can be obtained from a reaction with the non-polymeric acid having two or more pKa values ​​with the base(s) according to methods known to those skilled in the art. As a salt, mention may be made of metal salts, for example alkali metal salts such as Na and K and alkaline earth metal salts such as Mg and Ca and ammonium salts.

[0196] The (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof may be an organic acid or salt(s) thereof, and preferably an acid hydrophilic or water-soluble organic or salt(s) thereof.

[0197] The non-polymeric acid having two or more pKa values ​​may have at least two acid groups selected from the group consisting of a carboxylic group, a sulfuric group, a sulfonic group, a phosphoric group, a phosphonic group, a phenolic hydroxyl group and a mixture thereof.

[0198] The non-polymeric acid having two or more pKa values ​​may be a non-polymeric polyvalent acid.

[0199] The non-polymeric acid having two or more pKa values ​​may be selected from the group consisting of dicarboxylic acids, disulfonic acids and diphosphoric acids, as well as a mixture thereof.

[0200] The (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof may be selected from the group consisting of oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, fumaric acid, maleic acid, malic acid, citric acid, aconitic acid, oxaloacetic acid, tartaric acid and their salts; aspartic acid, glutamic acid and their salts; sulfonic terephthalylidene dicamphor acid or their salts (Mexoryl SX), Benzophenone-9; phytic acid and its salts;Red 2 (Amaranth), Red 102 (New Coccine), Yellow 5 (Tartrazine), Yellow 6 (Sunset Yellow FCF), Green 3 (Fast Green FCF), Blue 1 (Brillant blue FCF), Blue 2 (Indigo Carminé), Red 202 (Lithol Rubine B), (Lithol Rubine BCA), Red 204 (Lake Red CBA), Red 206 (Lithol Red CA), Red 207 (Lithol Red BA), Red 208 (Lithol Red SR), Red 219 (Brilliant Lake Red R), Red 220 (Deep Maroon), Red 227 (Fast Acid Magenta), Yellow 203 (Quinoline Yellow WS), Green 201 (Alizanine Cyanine Green F), Green 204 (Pyranine Conc), Green 205 (Light Green SF Yellowish), Blue 203 (Patent Blue CA), Blue 205 (Alfazurine FG), Red 401 (Violamine R), Red 405 (Permanent Re F5R), Red 502 (Ponceau 3R), Red 503 (Ponceau R), Red 504 (Ponceau SX), Green 401 (Naphthol Green B), Green 402 (Guinea Green B), and Black 401 (Naphthol Blue Black); acide folique, acide ascorbique, acide erythorbique et leurs sels ; cystine et ses sels ; EDTA et ses sels ; gly-cyrrhizine et ses sels ; et un mélange de ceux-ci. ;

[0201] It may be preferable that the (c) non-polymeric acid having two or more pKa values ​​or one or more of its salts is selected from the group consisting of terephthalidene sulfonic acid and its salts (Mexoryl SX), Yellow 6 (Sunset Yellow FCF), ascorbic acid, phytic acid and its salts, and a mixture thereof.

[0202] The amount of the (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more and, more preferably, 0.1% by weight or more, relative to the total weight of the composition.

[0203] The amount of the (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof in the composition according to the present invention may be 15% by weight or less, preferably 10% by weight or less, and more preferably 5% by weight or less, based on the total weight of the composition.

[0204] The amount of (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.1% to 5% by weight, relative to the total weight of the composition.

[0205] [Superabsorbent polymer]

[0206] The composition according to the present invention comprises (d) at least one superabsorbent polymer. Two or more different types of superabsorbent polymers may be used in combination. Thus, a single type of superabsorbent polymer or a combination of different types of superabsorbent polymers may be used.

[0207] By "superabsorbent polymer" is meant a polymer capable, in the dry state, of spontaneously absorbing at least 20 times its own weight of aqueous fluid, in particular water, and in particular distilled water. These superabsorbent polymers are described in the book "Absorbent Polymer Technology, Studies in Polymer Science 8" by L. Brannon-Pappas and R. Harland, published by Elsevier, 1990.

[0208] These polymers have a high capacity for absorbing and retaining water and aqueous fluids. After absorption of the aqueous liquid, the particles of the polymer thus impregnated with aqueous fluid remain insoluble in the aqueous fluid and thus retain their state of separate particles.

[0209] The (d) superabsorbent polymer may have a water absorption capacity ranging from 20 to 2000 times its own weight (i.e., from 20 g to 2000 g of water absorbed per gram of absorbent polymer), preferably from 30 to 1500 times and even more preferably from 50 to 1000 times. These water absorption characteristics are defined at a standard temperature (25°C) and pressure (760 mm Hg, i.e., 100,000 Pa) and for distilled water.

[0210] The value of the water absorption capacity of a polymer can be determined by dispersing 0.5 g of polymer(s) in 150 g of a water solution, waiting 20 minutes, filtering the unabsorbed solution through a 150 qm filter for 20 minutes and weighing the unabsorbed water.

[0211] The (d) superabsorbent polymer used in the composition of the present invention is in the form of particles which, once hydrated, swell with the formation of soft beads.

[0212] The average particle size of the (d) superabsorbent polymer is 5 qm or more, preferably 10 qm or more, and preferably 15 qm or more.

[0213] The average particle size of the (d) superabsorbent polymer is 500 pm or less, preferably 400 pm or less, and more preferably 300 pm or less.

[0214] Thus, the average particle size of the (d) superabsorbent polymer is from 5 pm to 500 pm, preferably from 10 pm to 400 pm, and more preferably from 15 pm to 300 pm.

[0215] The average particle according to the present invention may be a number average particle size. The number average particle size may be determined by microscopy. The average particle size may be represented by a Heywood diameter.

[0216] If a particle of the (d) superabsorbent polymer is an aggregate of primary particles, the particle size here corresponds to the size of the aggregate. Thus, in this case, the particle size corresponds to the size of a secondary particle.

[0217] Preferably, the (d) superabsorbent polymer used in the present invention may be provided in the form of spherical particles.

[0218] The (d) superabsorbent polymer used in the present invention may preferably be crosslinked acrylic homopolymers or copolymers which are preferably neutralized and which are provided in the form of particles.

[0219] As (d) superabsorbent polymer, mention may be made of:

[0220] Crosslinked (meth)acrylic acid or (meth)acrylate polymers, preferably crosslinked homopolymers or copolymers of (meth)acrylic acid and / or (meth)acrylate and more preferably crosslinked sodium polyacrylates, such as, for example, those sold under the names Octacare XI00, XI10 and RM 100 by Avecia, those sold under the names Flocare GB300 and Flosorb 500 by SNF, those sold under the names Luquasorb 1003, Luquasorb 1010, Luquasorb 1280 and Luquasorb 1100 by BASF, those sold under the names Water Lock G400 and G430 (INCI name: Acrylamide / Sodium Acrylate Copolymer) by Grain Processing, or Aqua Keep 10 SH NF supplied by Sumitomo Seika, or Aqupec MG N40R (INCI name: Sodium Carbomer) supplied by Sumitomo Seika, those (INCI name: Carbomer) sold under the names Aqupec HV-501E, Aqupec 505E, Aqupec 505ED, Aqupec 801EG, Aqupec 801EG-300, Aqupec 805EG, Aqupec 805EG-300 and Aqupec SW-705E supplied by Sumitomo Seika, and the names Carbopol 934 Polymer, Carbopol 940 Polymer,Carbopol 941 Polymer, Carbopol 980 Polymer and Carbopol 981 Polymer supplied by Lubrizol; ,

[0221] Starches grafted with one or more acrylic or acrylate polymer(s) (homopolymer or copolymer) and in particular sodium polyacrylate, such as those sold under the names Sanfresh ST-100C, ST100MC and IM-300MC by Sanyo Chemical Industries, or Makimousse 25 and Makimousse 12 by Daito Kasei Kogyo (INCI name: Sodium Polyacrylate Starch);

[0222] Hydrolyzed starches grafted by an acrylic polymer (homopolymer or copolymer), in particular the acryloacrylamide / sodium acrylate copolymer, such as those sold under the names Water Lock A-240, A-180, B-204, D-223, A-100, C-200 and D-223 by Grain Processing (INCI name: Starch / Acrylamide / Sodium Acrylate Copolymer);

[0223] Polymers based on starch, gum and cellulose derivatives, such as those comprising starch, guar gum and sodium carboxymethylcellulose, sold under the name Lysorb 220 by Lysac; and

[0224] their mixtures.

[0225] The (d) superabsorbent polymer may be chosen from crosslinked (meth)acrylic or (meth)acrylate polymers, starches grafted with one or more acrylic or acrylate polymer(s) and mixtures thereof.

[0226] Preferably, the (d) superabsorbent polymer may be chosen from crosslinked sodium polyacrylates in the form of particles with a number average size (or average diameter) of less than or equal to 100 microns, more preferably in the form of spherical particles. These polymers preferably have a water absorption capacity of 10 to 100 g / g, preferably 20 to 80 g / g and even better 50 to 70 g / g.

[0227] The amount of the (d) superabsorbent polymer(s) in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more and, more preferably, 0.1% by weight or more, relative to the total weight of the composition.

[0228] The amount of the (d) superabsorbent polymer(s) in the composition according to the present invention may be 15% by weight or less, preferably 10% by weight or less and, more preferably, 5% by weight or less, relative to the total weight of the composition.

[0229] The amount of the superabsorbent polymer(s) in the composition according to the present invention may be from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and, more preferably, from 0.1% to 5% by weight, relative to the total weight of the composition.

[0230] [Water]

[0231] The composition according to the present invention comprises (e) water.

[0232] The amount of (e) water in the composition according to the present invention may be 50% by weight or more, preferably 60% by weight or more, and more preferably 70% by weight or more, relative to the total weight of the composition.

[0233] The amount of (e) water in the composition according to the present invention may be 95% by weight or less, preferably 90% by weight or less and, more preferably, 85% by weight or less, relative to the total weight of the composition.

[0234] The amount of (e) water in the composition according to the present invention may be from 50% to 95% by weight, preferably from 60% to 90% by weight and, more preferably, from 70% to 85% by weight, relative to the total weight of the composition.

[0235] [pH]

[0236] The pH of the composition according to the present invention may be from 3 to 9, preferably from 3.3 to 8.5 and, more preferably, from 3.5 to 8.

[0237] At a pH between 3 and 9, the polyionic complex formed by ingredients (a) to (c) can be very stable.

[0238] The pH of the composition according to the present invention may be corrected by adding at least one alkaline agent and / or at least one acid, other than (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof. The pH of the composition according to the present invention may also be corrected by adding at least one buffering agent.

[0239] (Alkaline agent)

[0240] The composition according to the present invention may comprise at least one alkaline agent. Two or more alkaline agents may be used in combination. Thus, a single type of alkaline agent or a combination of different types of alkaline agents may be used.

[0241] The alkaline agent may be an inorganic alkaline agent. It is possible that the inorganic alkaline agent is selected from the group consisting of ammonia, alkali metal hydroxides, alkaline earth metal hydroxides, alkali metal phosphates and monohydrogen phosphates such as sodium phosphate or sodium monohydrogen phosphate.

[0242] Examples of inorganic alkali metal hydroxides include sodium hydroxide and potassium hydroxide. Examples of alkaline earth metal hydroxides include calcium hydroxide and magnesium hydroxide. As an inorganic alkali agent, sodium hydroxide is preferable.

[0243] The alkaline agent may be an organic alkaline agent. It is preferable that the organic alkaline agent is selected from the group consisting of monoamines and their derivatives; diamines and their derivatives; polyamines and their derivatives; basic amino acids and their derivatives; oligomers of basic amino acids and their derivatives; polymers of basic amino acids and their derivatives; urea and its derivatives and guanidine and its derivatives.

[0244] Examples of organic alkaline agents include alkanolamines such as mono-, di-, and triethanolamine, and isopropanolamine; urea, guanidine, and their derivatives; basic amino acids such as lysine, ornithine, or arginine; and diamines such as those described by the structure below: R R3 R2 R4

[0245] wherein R denotes an alkylene such as propylene optionally substituted by a hydroxyl or C1-C4 alkyl radical, and R2, R3 and R4 independently denote a hydrogen atom, an alkyl radical or a C1-C4 hydroxyalkyl radical, as exemplified by 1,3-propanediamine and its derivatives. Arginine, urea and monoethanolamine are preferable.

[0246] The alkaline agent(s) may be used in an amount ranging from 0.01% to 15% by weight, preferably from 0.02% to 10% by weight, and more preferably from 0.03% to 5% by weight, relative to the total weight of the composition, depending on their solubility.

[0247] (Acid)

[0248] The composition according to the present invention may comprise at least one acid. Two or more acids may be used in combination. Thus, a single type of acid or a combination of different types of acids may be used.

[0249] As the acid, mention may be made of all inorganic or organic acids, preferably inorganic, which are commonly used in cosmetic products. A monovalent acid and / or a polyvalent acid may be used. A monovalent acid such as citric acid, lactic acid, sulfuric acid, phosphoric acid and hydrochloric acid (HCl) may be used. HCl is preferable.

[0250] The acid(s) may be used in an amount ranging from 0.01% to 15% by weight, preferably from 0.02% to 10% by weight, and more preferably from 0.03% to 5% by weight, relative to the total weight of the composition, depending on their solubility. [0251 ] (Buffering agent)

[0252] The composition according to the present invention may comprise at least one buffering agent. Two or more buffering agents may be used in combination. Thus, a single type of buffering agent or a combination of different types of buffering agents may be used.

[0253] As a buffering agent, mention may be made of an acetate buffer (e.g., acetic acid + sodium acetate), a phosphate buffer (e.g., sodium dihydrogen phosphate + disodium hydrogen phosphate), a citrate buffer (e.g., citric acid + sodium citrate), a borate buffer (e.g., boric acid + sodium borate), a tartrate buffer (e.g., tartaric acid + sodium tartrate dihydrate), a Tris buffer (e.g., tris(hydroxymethyl)aminomethane) and a Hepes buffer (acid 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid).

[0254] [Oil]

[0255] The composition according to the present invention may comprise (f) at least one oil. If two or more oils are used, they may be the same or different.

[0256] Herein, the term "oil" means a fatty compound or substance which is in the form of a liquid or a paste (not solid) at room temperature (25°C) under atmospheric pressure (760 mmHg). As oils, those generally used in cosmetics can be used alone or in combination. These oils can be volatile or non-volatile.

[0257] The (f) oil may be a non-polar oil such as a hydrocarbon-based oil, a silicone oil or the like; a polar oil such as a vegetable or animal oil and an ester oil or an ether oil; or a mixture thereof.

[0258] The (f) oil may be selected from the group consisting of oils of vegetable or animal origin, synthetic oils, silicone oils, hydrocarbon oils and fatty alcohols.

[0259] Examples of vegetable oils include apricot oil, linseed oil, camellia oil, macadamia nut oil, corn oil, mink oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, jojoba oil, sunflower oil, almond oil, rapeseed oil, sesame oil, soybean oil, peanut oil and mixtures thereof.

[0260] Examples of animal oils include squalene and squalane.

[0261] Examples of synthetic oils include alkane oils such as isododecane and isohexadecane, ester oils, ether oils and artificial triglycerides.

[0262] The ester oils are preferably liquid esters of linear or branched C1-C26 saturated or unsaturated aliphatic monoacids or polyacids and linear or branched C1-C26 saturated or unsaturated aliphatic monoalcohols or polyalcohols, the total number of carbon atoms of the esters being greater than or equal to 10.

[0263] Preferably, for the monoalcohol esters, at least one of the alcohol and the acid from which the esters of the present invention are derived is branched.

[0264] Among the monoesters of monoacids and monoalcohols, mention may be made of ethyl palmitate, ethylhexyl palmitate, isopropyl palmitate, dicaprylyl carbonate, alkyl myristates such as isopropyl myristate or ethyl myristate, isocetyl stearate, 2-ethylhexyl isononanoate, isononyl isononanoate, isodecyl neopentanoate and isostearyl neopentanoate.

[0265] Esters of C4-C22 dicarboxylic or tricarboxylic acids and C1-C22 alcohols may also be used, as well as esters of monocarboxylic, dicarboxylic or tricarboxylic acids and dihydroxy, trihydroxy, tetrahydroxy or non-sugar pentahydroxy alcohols C4-C26.

[0266] Mention may in particular be made of the following compounds: diethyl sebacate; isopropyl lauroyl sarcosinate; diisopropyl sebacate; bis(2-ethylhexyl) sebacate; diisopropyl adipate; di-n-propyl adipate; dioctyl adipate; bis(2-ethylhexyl) adipate; diisostearyl adipate; bis(2-ethylethylethylyl) maleate; triisopropyl citrate; triisocetyl citrate; triisostearyl citrate; glyceryl trilactate; glyceryl trioctanoate; trioctyl dodecyl citrate; trioleyl citrate; neotyl glycol diheptanoate; diethylene glycol diisononanoate.

[0267] As ester oils, it is possible to use sugar esters and diesters of C6-C30 and preferably C12-C22 fatty acids. It is recalled that the term "sugar" designates oxygenated hydrocarbon compounds containing several alcohol functions, with or without aldehyde or ketone functions, and comprising at least 4 carbon atoms. These sugars can be monosaccharides, oligosaccharides or polysaccharides.

[0268] Examples of suitable sugars which may be mentioned include sucrose, glucose, galactose, ribose, fucose, maltose, fructose, mannose, arabinose, xylose, lactose and their derivatives, in particular alkylated derivatives, such as methyl derivatives, for example methylglucose.

[0269] The sugar esters of fatty acids may be chosen in particular from the group comprising the esters or mixtures of esters of the sugars described above and of linear or branched, saturated or unsaturated fatty acids in C6-C30> and preferably in C[2-C22. If they are unsaturated, these compounds may have one to three conjugated or unconjugated carbon-carbon double bonds.

[0270] The esters according to this variant can also be selected from monoesters, diesters, triesters, tetraesters, polyesters and mixtures thereof.

[0271] These esters may be, for example, oleates, laurates, palmitates, myristates, behenates, cocoates, stearates, linoleates, linolenates, caprates and arachidonates, or mixtures thereof such as, in particular, mixed esters of oleopalmitate, oleostearate and palmitostearate, as well as tetraethyl pentaerythrityl hexanoate.

[0272] More particularly, monoesters and diesters are used, and in particular monooleates or dioleates, stearates, behenates, oleopalmitates, linoleates, linolenates and oleostearates of sucrose, glucose or methylglucose.

[0273] An example that may be mentioned is the product sold under the name Glucate® DO by the company Amerchol which is a methylglucose dioleate.

[0274] Examples of preferred ester oils that may be mentioned include, for example, dii- adipate sopropyl, dioctyl adipate, 2-ethylhexyl hexanoate, ethyl laurate, cetyl octanoate, octyldodecyl octanoate, isodecyl neopentanoate, myristyl propionate, 2-ethylhexyl 2-ethylhexanoate, ethylhexyl 2-octanoate, 2-ethylhexyl caprylate / caprate, methyl palmitate, ethyl palmitate, isopropyl palmitate, dicaprylyl carbonate, isopropyl lauroyl sarcosinate, isononyl isononanoate, ethylhexyl palmitate, isohexyl laurate, hexyl laurate, isocetyl stearate, isopropyl isostearate, isopropyl myristate, isodecyl oleate, glyceryl tri(2-ethylhexanoate), pentaerythrithyl tetra(2-ethylhexanoate), 2-ethylhexyl succinate, diethyl sebacate, cetearyl isononanoate and mixtures thereof.

[0275] Examples of artificial triglycerides include, for example, capryl caprylyl glycerides, glyceryl trimyristate, glyceryl tripalmitate, glyceryl trilinolenate, glyceryl trilaurate, glyceryl tricaprate, glyceryl tricaprylate, glyceryl tri(caprate / caprylate) and glyceryl tri(caprate / caprylate / linolenate).

[0276] Examples of silicone oils include linear organopolysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane and the like; cyclic organopolysiloxanes such as cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, do-decamethylcyclohexasiloxane and the like; and mixtures thereof.

[0277] Preferably, the silicone oil is chosen from liquid polydialkylsiloxanes, in particular liquid polydimethylsiloxanes (PDMS) and liquid polyorganosiloxanes comprising at least one aryl group.

[0278] These silicone oils may also be organomodified. The organomodified silicones that may be used for the present invention are silicone oils as defined above and comprise in their structure one or more organofunctional groups attached via a hydrocarbon group.

[0279] Organopolysiloxanes are further defined in Walter Noll's Chemistry and Technology of Silicones (1968), Academie Press. They may be volatile or non-volatile.

[0280] When they are volatile, the silicones are more particularly chosen from those having a boiling point between 60°C and 260°C, and more particularly from:

[0281] (i) cyclic polydialkylsiloxanes comprising from 3 to 7 and preferably from 4 to 5 silicon atoms. These include, for example, octamethylcyclotetrasiloxane sold under the name Volatile Silicone® 7207 by Unioncarbure or Silbione® 70045 V2 by Rhodia, decamethylcyclopentasiloxane sold under the name Volatile Silicone® 7158 by Unioncarbure, Silbione® 70045 V5 by Rhodia, and dodecame- ethylcyclopentasiloxane sold under the name Silsoft 1217 by Momentive Performance Materials, and mixtures thereof. Other examples include cyclocopolymers of the dimethylsiloxane / methylalkylsiloxane type, such as Silicone Volatile® FZ 3109 sold by Union Carbide, with the formula: -D —D — CH, 1 CH. with 0* ; ""® ~ ° with DU "" If -■ o - CH,.

[0282] Mention may also be made of mixtures of cyclic polydialkylsiloxanes with organosilicon compounds, such as the mixture of octamethylcyclotetrasiloxane and tetramethylsilylpentaerythritol (50 / 50) and the mixture of octamethylcyclotetrasiloxane and oxy-1,r-bis(2,2',2',2',3,3'-hexatrimethylsilyloxy)neopentane; and

[0283] (ii) linear volatile polydialkylsiloxanes containing 2 to 9 silicon atoms and having a viscosity less than or equal to 5x106 m2 / s at 25 °C. An example is deca-methyltetrasiloxane sold in particular under the name SH 200 by the company Toray Silicone. Silicones belonging to this category are also described in the article published in Cosmetics and Toiletries, Vol. 91, Jan. 76, pp. 27-32, Todd & Byers, Volatile Silicone Fluids for Cosmetics. The viscosity of silicones is measured at 25 °C in accordance with ASTM 445 Appendix C.

[0284] Non-volatile polydialkylsiloxanes may also be used. These non-volatile silicones are more particularly chosen from polydialkylsiloxanes, among which mention may mainly be made of polydimethylsiloxanes containing trimethylsilyl end groups.

[0285] Among these polydialkylsiloxanes, the following commercial products may be mentioned, without limitation:

[0286] - Silbione® oils from the 47 and 70 047 ranges or Mirasil® oils sold by Rhodia, for example oil 70 047 V 500 000;

[0287] - oils from the Mirasil® range sold by the company Rhodia;

[0288] - oils from the 200 range of the Dow Corning company, such as DC200 with a viscosity of 60,000 mm2 / s; and

[0289] - Viscasil® oils from General Electric and certain oils from the SF range (SF 96, SF 18) from General Electric.

[0290] Mention may also be made of polydimethylsiloxanes containing dimethylsilanol end groups known as dimethiconol (CTFA), such as the oils of the 48 range from the company Rhodia.

[0291] Among the silicones containing aryl groups, mention may be made of polydiarylsiloxanes, in particular polydiphenylsiloxanes and polyalkylarylsiloxanes such as an oil of phenyl silicone.

[0292] The phenylated silicone oil may be chosen from phenyl silicones of the following formula:

[0293] in which

[0294] Ri to Rio are, independently of one another, saturated or unsaturated, linear, cyclic or branched C1-C30 hydrocarbon radicals, preferably C1-C12 hydrocarbon radicals and more preferably, C1-C6 hydrocarbon radicals, in particular methyl, ethyl, propyl or butyl radicals, and

[0295] m, n, p and q are, independently of each other, integers from 0 to 900 inclusive, preferably from 0 to 500 inclusive and more preferably from 0 to 100 inclusive,

[0296] provided that the sum n+m+q is not 0.

[0297] Products sold under the following names are examples that can be cited:

[0298] - Silbione® oils from the 70 641 range from Rhodia;

[0299] - oils from the Rhodorsil® 70 633 and 763 ranges from Rhodia;

[0300] - Dow Corning 556 Cosmetic Grade Fluid oil from Dow Corning;

[0301] - silicones from the Bayer PK range, such as the PK20 product;

[0302] - certain oils from the General Electric SF range, such as SF 1023, SF 1154, SF 1250 and SF 1265.

[0303] As phenyl silicone oil, phenyl trimethicone (Ri to Rio are methyl; p, q and n = 0; m = 1 in the above formula) is preferable.

[0304] Organomodified liquid silicones may in particular contain poly-ethyleneoxy and / or polypropyleneoxy groups. Examples include KF-6017 silicone offered by Shin-Etsu, and Silwet® L722 and L77 oils from Union Carbide.

[0305] The hydrocarbon oils can be chosen from:

[0306] - linear or branched lower alkanes, optionally cyclic, C6-C16. Examples that may be mentioned include hexane, undecane, dodecane, tridecane and isoparaffins, e.g. isohexadecane, isododecane and isodecane; and

[0307] - linear or branched hydrocarbons containing more than 16 carbon atoms, such as such as liquid paraffins, liquid petroleum jelly, polydecenes and hydrogenated polyisobutenes such as Parleam and squalane.

[0308] Preferred examples of hydrocarbon oils include, for example, linear or branched hydrocarbons such as isohexadecane, isododecane, squalane, mineral oil (e.g., liquid paraffin), paraffin, petrolatum or petroleum jelly, naphthalenes, and the like; hydrogenated polyisobutene, isoeicosane, and decene / butene copolymer and mixtures thereof.

[0309] The term "fatty" in fatty alcohol means the inclusion of a relatively large number of carbon atoms. Thus, alcohols that have 4 or more carbon atoms, preferably 6 or more, and most preferably 12 or more carbon atoms, are included within the scope of fatty alcohols. The fatty alcohol may be saturated or unsaturated. The fatty alcohol may be linear or branched.

[0310] The fatty alcohol may have the structure R-OH in which R is selected from saturated and unsaturated, linear and branched radicals containing from 4 to 40 carbon atoms, preferably from 6 to 30 carbon atoms and more preferably from 12 to 20 carbon atoms. In at least one embodiment, R may be selected from C12-C20 alkyl and C12-C20 alkenyl groups. R may or may not be substituted with at least one hydroxyl group.

[0311] Examples of fatty alcohol include lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecylenyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, oleyl alcohol, linoleyl alcohol, palmitoleyl alcohol, arachidonyl alcohol, erucyl alcohol and mixtures thereof.

[0312] It is preferable that the fatty alcohol is a saturated fatty alcohol.

[0313] Thus, the fatty alcohol may be chosen from saturated or unsaturated, linear or branched C6-C30 alcohols, preferably saturated, linear or branched C6-C30 alcohols, and more preferably, saturated, linear or branched C12-C20 alcohols.

[0314] The term "saturated fatty alcohol" herein refers to an alcohol having a long aliphatic saturated carbon chain. It is preferable that the saturated fatty alcohol is selected from any linear or branched saturated C6-C30 fatty alcohols. Among the linear or branched saturated C6-C30 fatty alcohols, linear or branched saturated C[2-C20] fatty alcohols may preferably be used. Any linear or branched saturated C16-C20 fatty alcohol may be more preferably used. Branched C16-C20 fatty alcohols may be even more preferably used.

[0315] Examples of saturated fatty alcohols include lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecylenyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol and mixtures thereof. In one embodiment, cetyl alcohol, stearyl alcohol, octyldodecanol, hexyldecanol, or a mixture thereof (e.g., cetearyl alcohol) as well as behenyl alcohol, may be used as the saturated fatty alcohol.

[0316] According to at least one embodiment, the fatty alcohol used in the composition according to the present invention is preferably chosen from octyldodecanol, hexyldecanol, and mixtures thereof.

[0317] According to the present invention, the (f) oil may be surrounded by a plurality of polyionic complex particles or the (f) oil may be present in the hollow portion of a capsule formed by the polyionic complex particles. In other words, the (f) oil may be covered by the polyionic complex particles, or a capsule formed by the polyionic complex particles includes the (f) oil in the hollow portion of the capsule.

[0318] The (f) oil which is surrounded by the polyionic complex particles or present in the hollow portion of the capsule formed by the polyionic complex particles cannot directly contact a keratinous substance such as skin. Thus, even if the (f) oil has a sticky or greasy feeling in use, the composition according to the present invention will not provide a sticky or greasy feeling in use.

[0319] The amount of the oil(s) in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more, and more preferably 0.1% by weight or more, relative to the total weight of the composition.

[0320] The amount of the oil(s) in the composition according to the present invention may be 50% by weight or less, preferably 40% by weight or less, and more preferably 30% by weight or less, relative to the total weight of the composition.

[0321] The amount of the oil(s) in the composition according to the present invention may be from 0.01% to 50% by weight, preferably from 0.05% to 40% by weight, and more preferably from 0.1% to 30% by weight, relative to the total weight of the composition.

[0322] [Optional Ingredients]

[0323] The composition according to the present invention may comprise, in addition to the above-mentioned components, at least one optional ingredient typically used in cosmetics, which may be chosen from, specifically, surfactants (in particular, non-ionic surfactants) or emulsifiers, hydrophilic or lipophilic thickeners, volatile or non-volatile organic solvents such as polyols, in particular glycols, silicones and silicone derivatives other than (f) oil, natural extracts derived from animals or vegetables, waxes, UV filters and the like, in a range which does not affect the effects of the present invention.

[0324] The composition according to the present invention may comprise the optional ingredient(s) in an amount of 0.01% to 50% by weight, preferably 0.05% to 30% by weight, and more preferably 0.1% to 10% by weight, relative to the total weight of the composition.

[0325] However, it is preferable that the composition according to the present invention includes a very limited amount of surfactant(s) or emulsifier(s). The amount of surfactant(s) or emulsifier(s) in the composition according to the present invention may be 1% by weight or less, preferably 0.1% by weight or less and, more preferably, 0.01% by weight or less, relative to the total weight of the composition. It is particularly preferable that the composition according to the present invention does not comprise any surfactant or emulsifier.

[0326] [Composition]

[0327] The composition according to the present invention can be used as a cosmetic composition. Thus, the cosmetic composition according to the present invention can be intended to be applied to a keratinous fiber. By keratinous substance is meant here a material containing keratin as a main constituent element, and by way of example, the skin, the scalp, the lips, the hair or body hair and the like. It is preferable that the cosmetic composition according to the present invention is used for a cosmetic process for the keratinous fiber, in particular the skin.

[0328] Thus, the composition according to the present invention may be a cosmetic composition for the skin, preferably a cosmetic skin care composition or a skin makeup composition, and more preferably a cosmetic skin care composition.

[0329] The composition according to the present invention can be prepared by mixing the above essential and optional ingredients according to any of the processes which are well known to those skilled in the art.

[0330] The composition according to the present invention can be prepared by simple or easy mixing with a conventional mixing means such as a stirrer. Therefore, there is no need for strong shearing, for example using a homogenizer. In addition, heating is not necessary.

[0331] If the composition according to the present invention includes the (f) oil(s), it may take the form of an emulsion, an O / W emulsion or a W / O emulsion. It is preferable that the composition according to the present invention is in the form of an O / W emulsion because it can offer a sensation of freshness due to the water which forms the external phase.

[0332] It is preferable that the amount of surfactant(s) or emulsifier(s) in the emulsion, in particular an O / W emulsion, is 3% by weight or less, preferably 2%. by weight or less, and more preferably 1% by weight or less, relative to the total weight of the composition, since the surfactant(s) may adversely affect the water resistance. It is particularly preferable that the emulsion, in particular an O / W emulsion, does not contain any surfactant or emulsifier.

[0333] The composition according to the present invention can be used to easily prepare a film, called the film according to the present invention. The (a) cationic polymer and the (b) anionic polymer, as well as the (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof, which can form a polyionic complex, can integrate to form a continuous film.

[0334] Thus, the present invention may also relate to a process for preparing a film, preferably a cosmetic film, optionally having a thickness of 0.1 qm or more, more preferably 1.5 qm or more, and even more preferably 2 qm or more, comprising:

[0335] the application to a substrate, preferably a keratinous substance, more preferably the skin, of the composition according to the present invention; and

[0336] drying the composition.

[0337] The upper limit of the thickness of the film according to the present invention is not limited. Thus, for example, the thickness of the film according to the present invention may be 1 mm or less, preferably 500 qm or less, more preferably 300 qm or less, and even more preferably 100 qm or less.

[0338] Since the above process for preparing the film according to the present invention comprises the steps of applying the composition according to the present invention to a substrate, preferably a keratinous substance, and more preferably the skin, and drying the composition, the process according to the present invention does not require spin coating or spraying, and therefore it is even possible to easily prepare a relatively thick film. Thus, the process for preparing the film according to the present invention can prepare a relatively thick film without any special equipment such as spin coating machines and spraying machines.

[0339] Even though the film according to the present invention is relatively thick, it is still thin and may be transparent, and therefore may not be easy to perceive. Thus, the film according to the present invention can be preferably used as a cosmetic film.

[0340] If the substrate is not a keratinous substance such as skin, the composition according to the present invention may be applied to a substrate made of any material other than keratin. The materials of the non-keratinous substrate are not limited. Two or more materials may be used in combination. Thus, a single type of material or a combination of different types of materials may be used. In any case, it is preferable that the substrate be soft or elastic.

[0341] If the substrate is not a keratinous substance, it is preferable that the substrate is water-soluble, since it is possible to leave the film according to the present invention by washing the substrate with water. As examples of the water-soluble materials, mention may be made of poly(methacrylic) acids, polyethylene glycols, polyacrylamides, polyvinyl alcohol (PVA), starch, cellulose acetates, and the like. PVA is preferable.

[0342] If the non-keratinous substrate is in the form of a sheet, it may have a thickness greater than that of the film according to the present invention, in order to facilitate the handling of the film attached to the substrate sheet. The thickness of the non-keratinous substrate sheet is not limited, but may be between 1 μm and 5 mm, preferably from 10 μm to 1 mm, and more preferably from 50 to 500 μm.

[0343] It is more preferable that the film according to the present invention can be released from the non-keratinous substrate. The release mode is not limited. Therefore, the film according to the present invention can be peeled off from the non-keratinous substrate, or released by dissolving the substrate sheet in a solvent such as water.

[0344] The present invention may also relate to:

[0345] (1) A film, preferably cosmetic, preferably of a thickness preferably greater than 0.1 pm, more preferably greater than 1.5 pm, and even more preferably greater than 2 pm, prepared by a process comprising:

[0346] the application to a substrate, preferably a keratinous substance, and more preferably to the skin, of the composition according to the present invention; and

[0347] drying the composition,

[0348] and

[0349] (2) A film, preferably a cosmetic film, optionally of a thickness su preferably greater than 0.1 pm, more preferably greater than 1.5 pm, even more preferably greater than 2 pm, comprising:

[0350] (a) at least one cationic polymer;

[0351] (b) at least one anionic polymer;

[0352] (c) at least one non-polymeric acid having two or more pKa values or salt(s) thereof;

[0353] optionally (f) at least one oil,

[0354] in which

[0355] the (b) anionic polymer is chosen from hyaluronic acids and their derivatives.

[0356] The above explanations concerning the (a) cationic and (b) anionic polymers as well as the (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof and the (f) oil can be applied to those of the films (1) and (2) above.

[0357] The film according to the present invention thus obtained above can be self-supporting. The term "self-supporting" means here that the film according to the present invention can be present in the form of a sheet and can be manipulated as an independent sheet without the assistance of a substrate or support. Thus, the term "self-supporting" can have the same meaning as "self-supporting".

[0358] It is preferable that the above film according to the present invention is hydrophobic.

[0359] In this specification, the term "hydrophobic" means that the solubility of the polymer in water (preferably with a volume of 1 liter) at 20-40°C, preferably 25-40°C, and more preferably 30-40°C is less than 10% by weight, preferably less than 5% by weight, more preferably less than 1% by weight, and even more preferably less than 0.1% by weight, relative to the total weight of the polymer. It is most preferable that the polymer is not soluble in water.

[0360] If the above film according to the present invention is hydrophobic, the film can have water-resistant properties and, therefore, it can remain on a keratinous substance such as skin, even if the surface of the keratinous substance is wet due to, for example, perspiration or rain. Thus, when the film according to the present invention provides a cosmetic effect, the cosmetic effect can last for a long time.

[0361] On the other hand, the film according to the present invention can be easily removed from a keratinous substance such as skin under alkaline conditions such as a pH of 8 to 12, preferably 9 to 11. Therefore, the film is difficult to remove with water, while it can be easily removed with a soap which can provide such alkaline conditions.

[0362] The film according to the present invention may comprise at least one layer of biocompatible and / or biodegradable polymer. Two or more biocompatible and / or biodegradable polymers may be used in combination. Thus, a single type of biocompatible and / or biodegradable polymer or a combination of different types of biocompatible and / or biodegradable polymers may be used.

[0363] The term "biocompatible" polymer in this specification means that the polymer does not have excessive interaction between the polymer and cells of the living body, including the skin, and that the polymer is not recognized by the living body as a foreign material.

[0364] The term "biodegradable" polymer in this specification means that the polymer can be degraded or broken down in a living body due to, for example, the metabolism of the living body itself or the metabolism of microorganisms that may be present in the living body. In addition, the biodegradable polymer can be degraded by hydrolysis.

[0365] If the film according to the present invention comprises a biocompatible and / or biodegradable polymer, it is less irritable or non-irritable to the skin, and does not cause any rash. Furthermore, due to the use of ... or biodegradable, the film according to the present invention can adhere well to the skin.

[0366] The film according to the present invention can be used for cosmetic treatments of keratinous substances, preferably the skin, in particular the face. The film according to the present invention can take any form. For example, it can be used as a full mask or as a patch for a part of the face such as the cheek, nose and eye contour.

[0367] If the film according to the present invention comprises at least one hydrophilic or water-soluble UV filter, it can provide UV screening effects derived from the hydrophilic or water-soluble UV filter. Normally, a hydrophilic or water-soluble UV filter can be removed from the surface of a keratinous substrate such as skin by water such as perspiration and rain. However, since the hydrophilic or water-soluble UV filter is included in the film, it is difficult to remove the hydrophilic or water-soluble UV filter with water, resulting in long-lasting UV screening effects.

[0368] [Cosmetic Process and Use]

[0369] The present invention also relates to:

[0370] a cosmetic process for a keratinous substance such as skin, comprising: applying to the keratinous substance the composition according to the present invention; and drying the composition to form a cosmetic film on the keratinous substance; and

[0371] a use of the composition according to the present invention for the preparation of a cosmetic film on a keratinous substance such as the skin.

[0372] The cosmetic process here designates a non-therapeutic cosmetic process for caring for and / or making up the surface of a keratinous substance such as the skin.

[0373] In both the above process and use, the above cosmetic film is resistant to water of a pH of 7 or less, and can be removed with water of a pH of more than 7, preferably 8 or more, and most preferably 9 or more.

[0374] In other words, the above film can be water-resistant under neutral or acidic conditions such as a pH of 7 or less, preferably in a range of 6 or more and 7 or less, and more preferably in a range of 5 or more and 7 or less, while the above cosmetic film can be removed under alkaline conditions such as a pH of more than 7, preferably 8 or more, and more preferably 9 or more. The upper limit of the pH is preferably 13, more preferably 12, and even more preferably 11.

[0375] Therefore, the above cosmetic film can be water-resistant and thus can remain on a keratinous substance such as skin even if the surface of the keratinous substance is wet due to, for example, perspiration or rain. On the other hand, the above cosmetic film can be easily removed from a keratinous substance such as skin under alkaline conditions. Therefore, the film according to the present invention is difficult to remove with water, while it can be easily removed with soap which can provide alkaline conditions.

[0376] If the above cosmetic film comprises a UV filter which may be present in the composition according to the present invention, the above cosmetic film can protect a keratinous substance such as skin from UV rays, thereby limiting the darkening of the skin, improving the color and uniformity of the complexion, and / or treating the aging of the skin.

[0377] Furthermore, the above cosmetic film may have cosmetic effects such as capturing sebum, mattifying the appearance of a keratin substrate such as skin, absorbing or absorbing a bad odor, and / or protecting the keratinous substance from, for example, dirt or pollution, due to the properties of the polyionic complex in the cosmetic film, even if the cosmetic film does not contain any cosmetic active ingredient.

[0378] Furthermore, the above cosmetic film can immediately change or modify the appearance of the skin by changing the reflection of light on the skin and the like, even if the cosmetic film does not contain any cosmetic active ingredient. Therefore, it is possible for the above cosmetic film to conceal skin defects such as pores or wrinkles. Furthermore, the above cosmetic film can immediately change or modify the touch feeling of the skin by changing the surface roughness of the skin and the like. Furthermore, the above cosmetic film can immediately protect the skin by covering the surface of the skin and shielding the skin, as a barrier, against environmental stresses such as pollutants, contaminants and the like.

[0379] The above cosmetic effects can be adjusted or controlled by changing the chemical composition, thickness and / or surface roughness of the above cosmetic film.

[0380] If the above cosmetic film contains at least one cosmetic active ingredient other than (f) oil, the cosmetic film may have cosmetic effects provided by the cosmetic active ingredient(s). For example, if the cosmetic film contains at least one cosmetic active ingredient selected from anti-aging agents, anti-sebum agents, deodorant agents, antiperspirant agents, whitening agents and a mixture thereof, the cosmetic film may treat skin aging, absorb sebum on the skin, control perspiration on the skin and / or whiten the skin.

[0381] It is also possible to apply a cosmetic makeup composition to the cosmetic film or sheet according to the present invention after its application to the skin. EXAMPLES

[0382] The present invention will be described in more detail with the aid of examples. However, these examples should not be construed as limiting the scope of the present invention. [Examples 1 to 3 and comparative examples 1 to 4]

[0383] [Preparation]

[0384] Each of the compositions according to Examples 1 to 3 and Comparative Examples 1 and 4 was prepared by mixing the ingredients listed in Table 1 in accordance with the following steps 1 to 8.

[0385] 1. The ingredients of Phase A were mixed and homogenized at 75°C+ / -5°C to obtain a mixture of Phase A.

[0386] 2. The ingredients of phase B were added to the resulting phase A mixture at step 1 and homogenized at 75°C+ / -5°C to obtain a mixture of phases A and B.

[0387] 3. The ingredient of phase C was added to the mixture of phases A and B above obtained in step 2 and homogenized at 75°C+ / -5°C to obtain a mixture of phases A, B and C.

[0388] 4. The ingredient of phase D was added to the above mixture of phases A, B and C obtained in step 3 and homogenized at 75°C+ / -5°C to obtain a mixture of phases A, B, CetD.

[0389] 5. The ingredient of Phase E was added to the mixture of phases A, B, C and D above- above obtained in step 4 and homogenized at 75°C+ / -5°C to obtain a mixture of Phases A, B, C, D and E.

[0390] 6. The ingredients of phase F were added to the mixture of phases A, B, C, D and E obtained in step 5, and homogenized at 75°C+ / -5°C to obtain a mixture of phases A, B, C, D, E and F.

[0391] 7. The ingredient of phase G was added to the above mixture of phases A, B, C, D, E and F obtained in step 6, and homogenized at room temperature to obtain a mixture of phases A, B, C, D, E, F and G.

[0392] 8. The ingredient of phase H was added to the mixture of phases A, B, C, D, E, F and G above obtained in step 7 and homogenized at room temperature to obtain a homogeneous composition.

[0393] The numerical values ​​of the quantities of ingredients in Table 1 are all based on a “% by weight” of raw materials.

[0394] (a) to (f) of Table 1 correspond to those of the claims.

[0395] [Tables 1] Phase Ex. 1 Ex. 2 Ex. 3 Ex. Ex. 1 Ex. comp. 2 Ex. Comp. 3 Ex. Comp. 4 A (e) Water qs 100 qs 100 qs 100 qs 100 qs 100 qs 100 qs 100 Propanediol 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Pentylene glycol 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Chlorphenesi ne 0.27 0.27 0.27 0.27 0.27 0.27 0.27 Ethylenedia mine trisodium di-succinate 0.20 0.20 0.20 0.20 0.20 0.20 0.20 Betaine 3.00 3.00 3.00 3.00 3.00 3.00 3.00 B Glyceryl Stearate Citrate 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Polyglyceryl-4 Caprate 0.20 0.20 0.20 0.20 0.20 0.20 0.20 (f) Behenyl Alcohol 2.00 2.00 2.00 2.00 2.00 2.00 2.00 (f) Isopropyl Myristate 5.00 5.00 5.00 5.00 5.00 5.00 5.00 (f) Cetearyl Isononanoate 0.50 0.50 0.50 0.50 0.50 0.50 0.50 (f) Squalane 0.50 0.50 0.50 0.50 0.50 0.50 0.50 C (a) Sodium hyaluronate 0.15 0.15 0.15 - 0.15 0.15 0.15 (1100kDa) (a) Sodium hyaluronate (50 kDa) 0.15 0.15 0.15 - 0.15 0.15 0.15 D (b) Polyepsilon-1 y sine 0.60 0.60 0.60 0.60 - 0.60 0.60 E (c) Phytic acid 0.17 0.17 0.17 0.17 0.17 - 0.17 F (d) Sodium starch polyacrylate (particle size: 35 pm) 0.75 0.75 0.75 0.75 (d) Sodium starch polyacrylate (particle size: 183 pm) 0.75 (d) Sodium carbomer (particle size: 90 pm) 0.75 Hectorite 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Crosslinked polymer of acrylates / C10-30 alkyl acrylate 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Xanthan gum 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Silica silylate 0.30 0.30 0.30 0.30 0.30 0.30 0.30 H Potassium Hydroxide qs qs qs qs qs qs qs Sebum Control Good Good Good Bad s Bad Bad Bad Noodle Good Good Good Bad s Bad Bad Good Stability Good Good Good Good Good Good Bad e

[0396] Particle size: number average particle size determined by microscopy

[0397] [Evaluations]

[0398] (Serum control)

[0399] Each of the compositions according to Examples 1-3 and Comparative Examples 1-4 was spread on a contrast sheet with an automatic film applicator to form a 100 qm layer and allowed to dry at 37°C for 24 hours. Then, an artificial sebum / sweat composition with the formulation shown in the following Table 2 was sprayed onto the layer above on the contrast card at room temperature. The amount of the artificial sebum / sweat composition sprayed onto each of the above layers was the same.

[0400] [Tables2] (% by weight) Oleic acid 20.0 Poly(oxy-1,2-ethanediyl) 1.0 Water 79.0 Total 100.0

[0401] After 24 hours, the surface roughness of the layer above was observed by a confocal microscope. The surface roughness was evaluated according to the following criteria:

[0402] Good High surface roughness

[0403] Poor Low surface roughness

[0404] High surface roughness means that the layer absorbed the artificial sebum / sweat composition and kept it there for a long time. High surface roughness is also good for exhibiting a matte effect. Thus, high surface roughness reflects good sebum control effects.

[0405] The compositions according to Examples 1-3 were able to form a sufficiently rough. On the other hand, the compositions according to Comparative Examples 1-4 could not form a sufficiently rough surface. These results reflect the fact that a combination of a polyionic complex and a superabsorbent polymer can provide enhanced anti-sebum effects that can contribute to a matte appearance.

[0406] (Noodle)

[0407] The artificial sebum / sweat composition with the formulation shown in Table 2 above was applied to bioskin. Then, each of the compositions according to Examples 1-3 and Comparative Examples 1-4 was applied to the bioskin, and spread with a finger, and then dried at 40°C. Then, a foundation was applied thereon and rubbed. The noodle formation of the foundation was evaluated according to the following criteria.

[0408] Good: No or few noodles were observed

[0409] Bad: Noodles were observed noticeably

[0410] Noodles: Aggregation that appears as a gum residue produced during application

[0411] The compositions according to Examples 1-3 induced little or no noodles. On the other hand, the compositions according to Comparative Examples 1-3 induced a significant number of noodles. These results reflect the fact that the polyionic complex can suppress noodle formation.

[0412] (Stability)

[0413] Each of the compositions according to Examples 1-3 and Comparative Examples 1-4 was stored in a transparent container at 45°C for 2 months. The stability of the compositions was visually observed and evaluated according to the following criteria.

[0414] Good: The uniformity of the composition was maintained.

[0415] Poor: Composition uniformity was not maintained (water release or phase separation was significantly observed).

[0416] The results are shown in Table 1.

[0417] The compositions according to Examples 1 to 3 were stable. On the other hand, the composition according to Comparative Example 4 was unstable. These results reflect the fact that a superabsorbent polymer can enhance the stability of a composition comprising a polyionic complex.

Claims

Claims

1. A composition, comprising: (a) at least one cationic polymer; (b) at least one anionic polymer; (c) at least one non-polymeric acid having two or more pKa values ​​or salt(s) thereof; (d) at least one superabsorbent polymer; and (e) water, wherein the (b) anionic polymer is selected from hyaluronic acids and their derivatives, and the (d) superabsorbent polymer is in the form of particles with an average particle size of 5 qm to 500 qm, preferably 10 qm to 400 qm, and more preferably 15 qm to 300 qm.

2. The composition of claim 1, wherein the (a) cationic polymer comprises at least one positively chargeable and / or positively charged moiety selected from the group consisting of a primary, secondary or tertiary amino group, a quaternary ammonium group, a guanidine group, a biguanide group, an imidazole group, an imino group and a pyridyl group.

3. A composition according to claim 1 or 2, wherein the (a) cationic polymer is selected from the group consisting of alkyldiallylamine cyclopolymers and dialkyldiallylammonium cyclopolymers such as (co)polydiallyldialkyl ammonium chloride, (co)polyamines such as chitosans and (co)polylysines, cationic (co)polyamino acids such as collagen, cationic cellulose polymers and their salts.

4. A composition according to any one of claims 1 to 3, wherein the composition comprises at least two hyaluronic acids of different molecular weight, preferably a first hyaluronic acid of a molecular weight less than or equal to 100 kDa and a second hyaluronic acid of a molecular weight greater than or equal to 500 kDa, and more preferably a first hyaluronic acid of a molecular weight less than or equal to 50 kDa and a second hyaluronic acid of a molecular weight greater than or equal to 1000 kDa, as the (b) anionic polymers.

5. A composition according to any one of Claims 1 to 4, in wherein the (c) non-polymeric acid having two or more pKa values ​​or salt(s) thereof is an organic acid or salt(s) thereof, preferably a hydrophilic or water-soluble organic acid or salt(s) thereof, and more preferably phytic acid or salts thereof.

6. Composition according to any one of claims 1 to 5, in which the (d) superabsorbent polymer is selected from crosslinked (meth)acrylic or (meth)acrylate polymers, starches grafted with one or more acrylic or acrylate polymers, and mixtures thereof.

7. Composition according to any one of claims 1 to 6, in which the pH of the composition is between 3 and 9, preferably between 3.3 and 8.0, and more preferably between 3.5 and 8.

8. A composition according to any one of claims 1 to 7, the composition further comprising (f) at least one oil.

9. A composition according to any one of claims 1 to 8, wherein the composition is a cosmetic composition, preferably a cosmetic composition for the skin, and more preferably, a cosmetic skin care composition.

10. A cosmetic process for a keratinous substance such as skin, comprising applying to the keratinous material the composition according to any one of claims 1 to 9; and drying the composition to form a cosmetic film on the keratinous substance.